These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8188209)
1. Studies show AIDS often lags behind HIV ten years or more; cost of AIDS treatment declines. Hosp Community Psychiatry; 1994 Mar; 45(3):288-9. PubMed ID: 8188209 [No Abstract] [Full Text] [Related]
2. AIDS is your business. Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655 [TBL] [Abstract][Full Text] [Related]
3. [Ten years of commitment to persons living with HIV-AIDS: evaluation of the management in three ambulatory treatment centers of the French Red Cross in Africa]. Mouala C; Madec Y; Adam G; Courpotin C; Fikouma V; Gentilini M; Ould Mohamedoune A; Nzounza P; Schaer E; Simon B; Mattei JF Sante; 2008; 18(2):89-95. PubMed ID: 19188132 [TBL] [Abstract][Full Text] [Related]
4. Economic impact of delaying or preventing AIDS in persons with HIV. Pinkerton SD; Holtgrave DR Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025 [TBL] [Abstract][Full Text] [Related]
5. Fewer AIDS deaths and illnesses: new information. James JS AIDS Treat News; 1997 Feb; (No 265):1-3. PubMed ID: 11364239 [TBL] [Abstract][Full Text] [Related]
6. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Hall HI; McDavid K; Ling Q; Sloggett A Ann Epidemiol; 2006 Nov; 16(11):824-33. PubMed ID: 17067817 [TBL] [Abstract][Full Text] [Related]
7. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117 [TBL] [Abstract][Full Text] [Related]
8. Economic consequences of HIV/AIDS in India. Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706 [TBL] [Abstract][Full Text] [Related]
9. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna. Armbruster C; Kriwanek S; Vorbach H Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro. Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762 [TBL] [Abstract][Full Text] [Related]
11. Economic causes and effects of AIDS in South African households. Bachmann MO; Booysen FL AIDS; 2006 Sep; 20(14):1861-7. PubMed ID: 16954727 [TBL] [Abstract][Full Text] [Related]
12. Update: mortality attributable to HIV infection/AIDS among persons aged 25-44 years--United States, 1990 and 1991. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(25):481-6. PubMed ID: 8510635 [TBL] [Abstract][Full Text] [Related]
13. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485 [TBL] [Abstract][Full Text] [Related]
14. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000. Lai DJ; Tarwater PM; Hardy RJ Public Health; 2006 Jun; 120(6):486-92. PubMed ID: 16730037 [TBL] [Abstract][Full Text] [Related]
15. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. Boerma JT; Nunn AJ; Whitworth JA AIDS; 1998; 12 Suppl 1():S3-14. PubMed ID: 9677185 [TBL] [Abstract][Full Text] [Related]
16. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Stover J; Bertozzi S; Gutierrez JP; Walker N; Stanecki KA; Greener R; Gouws E; Hankins C; Garnett GP; Salomon JA; Boerma JT; De Lay P; Ghys PD Science; 2006 Mar; 311(5766):1474-6. PubMed ID: 16456039 [TBL] [Abstract][Full Text] [Related]
17. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Williams BG; Dye C Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302 [TBL] [Abstract][Full Text] [Related]
18. The role of cholecystectomy in acquired immunodeficiency syndrome. Flum DR; Steinberg SD; Sarkis AY; Pacholka JR; Wallack MK J Am Coll Surg; 1997 Mar; 184(3):233-9. PubMed ID: 9060917 [TBL] [Abstract][Full Text] [Related]
19. Rate of hospitalization and inpatient care costs for HIV-1-infected patients in Pune, India. Ghate MV; Tripathy SP; Kumar BK; Godbole SV; Chittake A; Nyayanirgune P; Gangakhedkar RR; Divekar AD; Thakar MR; Risbud AR; Bollinger RC; Mehendale SM Natl Med J India; 2006; 19(1):10-4. PubMed ID: 16570678 [TBL] [Abstract][Full Text] [Related]
20. [Survival analysis of 530 HIV infected former unsafe commercial blood and plasma donors]. Dou ZH; Yu L; Zhao HX; Ma Y; Peng GP; Lu LX; Li ZH; Fu JH; Zhang FJ Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):879-83. PubMed ID: 19141220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]